See more : C.H. Robinson Worldwide, Inc. (CHRW) Income Statement Analysis – Financial Results
Complete financial analysis of NewAge, Inc. (NBEV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NewAge, Inc., a leading company in the Beverages – Non-Alcoholic industry within the Consumer Defensive sector.
- Promotora Ambiental, S.A.B. de C.V. (PASAB.MX) Income Statement Analysis – Financial Results
- Fraser and Neave, Limited (FNEVF) Income Statement Analysis – Financial Results
- SELLAS Life Sciences Group, Inc. (SLS) Income Statement Analysis – Financial Results
- New World Gold Corp. (NWGC) Income Statement Analysis – Financial Results
- Enerplus Corporation (ERF.TO) Income Statement Analysis – Financial Results
NewAge, Inc. (NBEV)
About NewAge, Inc.
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado. On August 30, 2022, NewAge, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 279.47M | 253.71M | 52.16M | 52.19M | 25.30M | 0.00 | 1.04M | 968.94K |
| Cost of Revenue | 101.98M | 101.00M | 42.87M | 39.79M | 19.51M | 0.00 | 879.46K | 684.59K |
| Gross Profit | 177.49M | 152.71M | 9.30M | 12.40M | 5.80M | 0.00 | 164.19K | 284.35K |
| Gross Profit Ratio | 63.51% | 60.19% | 17.82% | 23.76% | 22.91% | 0.00% | 15.73% | 29.35% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 113.21M | 0.00 | 20.29M | 14.61M | 7.84M | 0.00 | 1.28M | 415.09K |
| Selling & Marketing | 0.00 | 0.00 | 2.78M | 3.84M | 1.58M | 0.00 | 155.98K | 174.01K |
| SG&A | 113.21M | 0.00 | 23.07M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Other Expenses | 99.13M | 199.33M | 2.31M | 668.05M | 1.47M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 212.34M | 199.33M | 25.38M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Cost & Expenses | 314.32M | 300.33M | 68.24M | 58.24M | 28.93M | 0.00 | 2.32M | 1.27M |
| Interest Income | 0.00 | -227.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.38M | 3.90M | 1.07M | 228.04K | 299.08K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.93M | 8.76M | 2.31M | 1.61M | 523.75K | 77.82K | 169.40K | 103.21K |
| EBITDA | -29.93M | -64.50M | -17.68M | -1.70M | -2.81M | 0.00 | -1.08M | -227.14K |
| EBITDA Ratio | -10.71% | -25.42% | -33.90% | -3.26% | -11.11% | 0.00% | -103.52% | -23.44% |
| Operating Income | -34.85M | -80.00M | -19.37M | -6.05M | -3.63M | 0.00 | -1.28M | -304.75K |
| Operating Income Ratio | -12.47% | -31.53% | -37.14% | -11.59% | -14.33% | 0.00% | -122.27% | -31.45% |
| Total Other Income/Expenses | -2.60M | -98.17M | -1.69M | 2.51M | -6.32K | 0.00 | 26.32K | -25.59K |
| Income Before Tax | -37.45M | -77.17M | -21.06M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Income Before Tax Ratio | -13.40% | -30.42% | -40.38% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| Income Tax Expense | -1.90M | 12.67M | -8.93M | 2.74M | 292.76K | 0.00 | 26.32K | -25.59K |
| Net Income | -39.34M | -89.84M | -12.14M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Net Income Ratio | -14.08% | -35.41% | -23.26% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| EPS | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| EPS Diluted | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| Weighted Avg Shares Out | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
| Weighted Avg Shares Out (Dil) | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
New Age: Four Catalysts That We Like Including A Valuation That Is Too Cheap To Ignore
NewAge, Inc. Delays Fourth Quarter and Full Year 2021 Financial Results Conference Call
NewAge to weigh reverse stock split to regain Nasdaq listing requirement
NewAge, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 16
Newage (NBEV) Stock: Why The Price Surged
4 Penny Stocks To Watch This Week
NewAge's (NBEV) CEO Brent Willis on Q3 2021 Results - Earnings Call Transcript
NewAge, Inc. Announces Timing for Third Quarter 2021 Financial Results and Conference Call
NewAge Recognized as Grand Winner in the 2021 American Best in Business Awards
NewAge Publishes Major New Discovery on Blocking Spike Proteins From Binding to Human Cells
Source: https://incomestatements.info
Category: Stock Reports